Open AccessProblem of Drug Interactions in the Treatment of Patients with COVID-19 and Comorbid Conditions
Author(s) -
Р. М. Арамисова,
З. А. Камбачокова,
Z. A. Akhkubekova,
Л. Л. Логвина,
М. М. Сарбашева,
S. M. Chudopal,
Л. Б. Тлапшокова,
Leylya M. Taukenova,
A. R. Tambiev,
Каземир Русланович Пшуков
Publication year - 2021
Publication title -
antibiotiki i himioterapiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.112
H-Index - 11
ISSN - 0235-2990
DOI - 10.37489/0235-2990-2021-66-7-8-45-49
Subject(s) - covid-19 , concomitant , drug , medicine , intensive care medicine , coronavirus , comorbidity , disease , drug treatment , drug repositioning , pharmacology , virology , infectious disease (medical specialty) , outbreak
The article discusses the issues of drug interactions in the treatment of COVID-19 patients with concomitant cardiovascular diseases. It was revealed, that the most frequent comorbid background in patients with COVID-19 is cardiac pathology. Cardiac arrhythmias are observed in many cases, which can be aggravated by the proarrhythmogenic eect of drugs used to treat the novel coronavirus disease.